RESEARCH

The Science Behind Prevagen

Madison Memory Study

In a double-blinded, placebo-controlled trial, Prevagen demonstrated the ability to improve aspects of cognitive function in participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening. The group of participants taking Prevagen improved certain aspects of cognitive function according to computer-based testing. The adults were over 40 years old and took one capsule daily (10 mg) for 90 days.
View The Study

Madison Memory Study

In a double-blinded, placebo-controlled trial, Prevagen demonstrated the ability to improve aspects of cognitive function in participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening. The group of participants taking Prevagen improved certain aspects of cognitive function according to computer-based testing. The adults were over 40 years old and took one capsule daily (10 mg) for 90 days.
View The Study

Safety Study I

The unique ingredient in Prevagen, apoaequorin, was evaluated for safety using a toxicity study, a common method for evaluating dietary supplements. In doses much higher than can be reasonably consumed (4,000 times the recommended daily amount of Prevagen Regular Strength) apoaequorin showed no adverse effects when taken orally.
Read The Summary

Safety Study I

The unique ingredient in Prevagen, apoaequorin, was evaluated for safety using a toxicity study, a common method for evaluating dietary supplements. In doses much higher than can be reasonably consumed (4,000 times the recommended daily amount of Prevagen Regular Strength) apoaequorin showed no adverse effects when taken orally.
Read The Summary

Safety Study II

In a separate safety study, Apoaequorin has not shown to have any significant risk of allergic reactivity when ingested.
Read The Summary

Safety Study II

In a separate safety study, Apoaequorin has not shown to have any significant risk of allergic reactivity when ingested.
Read The Summary

Safety Study III

In a third study conducted on the safety of apoaequorin, the protocol followed was very similar to Safety Study I, however, in this instance, the dosage was increased. Apoaequorin has been found to be safely consumed in doses much higher than recommended dosage (16,000 times the recommended daily amount of Prevagen Regular Strength).
Read The Summary

Safety Study III

In a third study conducted on the safety of apoaequorin, the protocol followed was very similar to Safety Study I, however, in this instance, the dosage was increased. Apoaequorin has been found to be safely consumed in doses much higher than recommended dosage (16,000 times the recommended daily amount of Prevagen Regular Strength).
Read The Summary

Ongoing Research Partnerships

Since the company’s beginning in 2004, Quincy Bioscience has partnered with leading researchers and universities in the United States and globally. This commitment to pioneering research in order to advance our understanding and drive innovation to help support humans and animals in aging remains strong and continues to the present day. Without original research spearheaded by Quincy Bioscience, these advances would not be possible.

Ongoing Research Partnerships

Since the company’s beginning in 2004, Quincy Bioscience has partnered with leading researchers and universities in the United States and globally. This commitment to pioneering research in order to advance our understanding and drive innovation to help support humans and animals in aging remains strong and continues to the present day. Without original research spearheaded by Quincy Bioscience, these advances would not be possible.

 

Quincy Bioscience – The Makers of Prevagen
Interested in Prevagen?
Buy Direct from the Manufacturer
With FREE SHIPPING!
Don't miss out. Order Today.
×
×